Morrison & Foerster senior partner James Brosnahan just couldn't talk the government down. A grand jury indicted his client, Scott Harkonen, former CEO of the California biotech firm InterMune Inc., Tuesday for fraudulently marketing the company's drug Actimmune. The decision marks a rare instance in which the Justice Department has gone criminal against an individual executive for off-label marketing abuses, rather than just reaching a deferred prosecution agreement with the drug company.
Font Size: 
Biotech Executive Indicted for Off-Label Claims
The Recorder
March 19, 2008
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.
